Structure

Physi-Chem Properties

Molecular Weight:  478.33
Volume:  512.007
LogP:  4.83
LogD:  3.765
LogS:  -5.127
# Rotatable Bonds:  8
TPSA:  85.22
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.399
Synthetic Accessibility Score:  4.967
Fsp3:  0.821
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.688
MDCK Permeability:  1.9031429474125616e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.091
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.092
Plasma Protein Binding (PPB):  85.48563385009766%
Volume Distribution (VD):  1.939
Pgp-substrate:  13.23405933380127%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.284
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.809
CYP2C9-inhibitor:  0.142
CYP2C9-substrate:  0.083
CYP2D6-inhibitor:  0.019
CYP2D6-substrate:  0.204
CYP3A4-inhibitor:  0.768
CYP3A4-substrate:  0.301

ADMET: Excretion

Clearance (CL):  1.923
Half-life (T1/2):  0.174

ADMET: Toxicity

hERG Blockers:  0.11
Human Hepatotoxicity (H-HT):  0.341
Drug-inuced Liver Injury (DILI):  0.301
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.367
Maximum Recommended Daily Dose:  0.067
Skin Sensitization:  0.305
Carcinogencity:  0.255
Eye Corrosion:  0.094
Eye Irritation:  0.032
Respiratory Toxicity:  0.975

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474835

Natural Product ID:  NPC474835
Common Name*:   7Alpha-Hydroperoxylabda-8(17),14-Dien-13(R)-Ol-4-O-Acetyl-Alpha-L-6-Deoxyidopyranoside
IUPAC Name:   [(2S,3S,4R,5R,6S)-6-[(3R)-5-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl] acetate
Synonyms:  
Standard InCHIKey:  ZTNQJRLNKSLKMO-QQYBNUSVSA-N
Standard InCHI:  InChI=1S/C28H46O6/c1-9-27(7,34-25-23(31)22(30)24(18(3)32-25)33-19(4)29)16-13-20-17(2)11-12-21-26(5,6)14-10-15-28(20,21)8/h9,18,20-25,30-31H,1-2,10-16H2,3-8H3/t18-,20-,21-,22+,23+,24+,25-,27-,28+/m0/s1
SMILES:  C=C[C@](O[C@@H]1O[C@@H](C)[C@H]([C@@H]([C@H]1O)O)OC(=O)C)(CC[C@H]1C(=C)CC[C@@H]2[C@]1(C)CCCC2(C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL484445
PubChem CID:   44575995
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16949 Aster oharai Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[12193011]
NPO16949 Aster oharai Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT148 Cell Line HCT-15 Homo sapiens ED50 = 1.1 ug ml-1 PMID[570024]
NPT390 Cell Line LOX IMVI Homo sapiens ED50 = 1.5 ug ml-1 PMID[570024]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 = 1.3 ug ml-1 PMID[570024]
NPT383 Cell Line SNB-19 Homo sapiens ED50 = 1.3 ug ml-1 PMID[570024]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474835 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9341 High Similarity NPC91197
0.9341 High Similarity NPC125551
0.9341 High Similarity NPC155319
0.9341 High Similarity NPC309503
0.9341 High Similarity NPC239547
0.9341 High Similarity NPC96597
0.8901 High Similarity NPC67398
0.8901 High Similarity NPC91654
0.8901 High Similarity NPC474792
0.8889 High Similarity NPC474249
0.8889 High Similarity NPC261990
0.8842 High Similarity NPC280991
0.8602 High Similarity NPC211238
0.8587 High Similarity NPC289361
0.8557 High Similarity NPC470571
0.8526 High Similarity NPC473555
0.8526 High Similarity NPC471770
0.8526 High Similarity NPC278939
0.8511 High Similarity NPC286612
0.8511 High Similarity NPC230347
0.8511 High Similarity NPC275310
0.8438 Intermediate Similarity NPC477928
0.8438 Intermediate Similarity NPC157739
0.8404 Intermediate Similarity NPC178949
0.8404 Intermediate Similarity NPC96736
0.8387 Intermediate Similarity NPC302584
0.8367 Intermediate Similarity NPC154452
0.8351 Intermediate Similarity NPC317019
0.8317 Intermediate Similarity NPC392
0.8317 Intermediate Similarity NPC177524
0.8317 Intermediate Similarity NPC219900
0.83 Intermediate Similarity NPC239961
0.83 Intermediate Similarity NPC470767
0.83 Intermediate Similarity NPC470763
0.8265 Intermediate Similarity NPC21064
0.8265 Intermediate Similarity NPC21568
0.8265 Intermediate Similarity NPC198992
0.8265 Intermediate Similarity NPC121072
0.8265 Intermediate Similarity NPC285231
0.8261 Intermediate Similarity NPC263079
0.8229 Intermediate Similarity NPC90583
0.8211 Intermediate Similarity NPC305160
0.8182 Intermediate Similarity NPC121423
0.8173 Intermediate Similarity NPC473125
0.8172 Intermediate Similarity NPC309310
0.8172 Intermediate Similarity NPC473058
0.8163 Intermediate Similarity NPC477721
0.8163 Intermediate Similarity NPC477716
0.8144 Intermediate Similarity NPC240372
0.8132 Intermediate Similarity NPC34581
0.8119 Intermediate Similarity NPC473199
0.8119 Intermediate Similarity NPC82251
0.8095 Intermediate Similarity NPC44298
0.8095 Intermediate Similarity NPC473159
0.8095 Intermediate Similarity NPC473128
0.8095 Intermediate Similarity NPC290608
0.8095 Intermediate Similarity NPC40133
0.8095 Intermediate Similarity NPC49413
0.8085 Intermediate Similarity NPC159876
0.8085 Intermediate Similarity NPC202886
0.8085 Intermediate Similarity NPC471370
0.8085 Intermediate Similarity NPC471371
0.8081 Intermediate Similarity NPC477717
0.8081 Intermediate Similarity NPC154127
0.8058 Intermediate Similarity NPC206618
0.8043 Intermediate Similarity NPC471369
0.8039 Intermediate Similarity NPC472390
0.8039 Intermediate Similarity NPC33053
0.8022 Intermediate Similarity NPC166279
0.8021 Intermediate Similarity NPC72817
0.8021 Intermediate Similarity NPC477927
0.802 Intermediate Similarity NPC31430
0.802 Intermediate Similarity NPC470768
0.802 Intermediate Similarity NPC85593
0.802 Intermediate Similarity NPC173583
0.8019 Intermediate Similarity NPC471633
0.8019 Intermediate Similarity NPC69576
0.8019 Intermediate Similarity NPC84949
0.8019 Intermediate Similarity NPC31354
0.8 Intermediate Similarity NPC177701
0.8 Intermediate Similarity NPC94919
0.8 Intermediate Similarity NPC48463
0.7981 Intermediate Similarity NPC83005
0.7979 Intermediate Similarity NPC477748
0.7961 Intermediate Similarity NPC128795
0.7961 Intermediate Similarity NPC38217
0.7961 Intermediate Similarity NPC217921
0.7961 Intermediate Similarity NPC38948
0.7961 Intermediate Similarity NPC135015
0.7961 Intermediate Similarity NPC48548
0.7961 Intermediate Similarity NPC472988
0.7959 Intermediate Similarity NPC477719
0.7959 Intermediate Similarity NPC98112
0.7959 Intermediate Similarity NPC97867
0.7959 Intermediate Similarity NPC477718
0.7944 Intermediate Similarity NPC199428
0.7944 Intermediate Similarity NPC5311
0.7944 Intermediate Similarity NPC193382
0.7944 Intermediate Similarity NPC99620
0.7944 Intermediate Similarity NPC310341
0.7941 Intermediate Similarity NPC165405
0.7935 Intermediate Similarity NPC164424
0.7925 Intermediate Similarity NPC75167
0.7925 Intermediate Similarity NPC264153
0.7925 Intermediate Similarity NPC311592
0.7921 Intermediate Similarity NPC473124
0.7921 Intermediate Similarity NPC281378
0.7921 Intermediate Similarity NPC473123
0.79 Intermediate Similarity NPC11974
0.7885 Intermediate Similarity NPC43976
0.7885 Intermediate Similarity NPC296761
0.7885 Intermediate Similarity NPC125361
0.7885 Intermediate Similarity NPC40728
0.7885 Intermediate Similarity NPC51925
0.7885 Intermediate Similarity NPC154085
0.7885 Intermediate Similarity NPC473570
0.7885 Intermediate Similarity NPC316974
0.7879 Intermediate Similarity NPC469725
0.7879 Intermediate Similarity NPC158088
0.7879 Intermediate Similarity NPC312325
0.7872 Intermediate Similarity NPC248312
0.787 Intermediate Similarity NPC99728
0.787 Intermediate Similarity NPC473852
0.787 Intermediate Similarity NPC203862
0.787 Intermediate Similarity NPC471355
0.787 Intermediate Similarity NPC158344
0.787 Intermediate Similarity NPC93883
0.787 Intermediate Similarity NPC27507
0.787 Intermediate Similarity NPC471353
0.787 Intermediate Similarity NPC34390
0.787 Intermediate Similarity NPC474418
0.787 Intermediate Similarity NPC77319
0.787 Intermediate Similarity NPC87250
0.787 Intermediate Similarity NPC196429
0.787 Intermediate Similarity NPC142066
0.787 Intermediate Similarity NPC243196
0.787 Intermediate Similarity NPC50305
0.787 Intermediate Similarity NPC471351
0.787 Intermediate Similarity NPC290693
0.787 Intermediate Similarity NPC309034
0.787 Intermediate Similarity NPC244402
0.787 Intermediate Similarity NPC152615
0.787 Intermediate Similarity NPC157376
0.787 Intermediate Similarity NPC471354
0.787 Intermediate Similarity NPC84987
0.7864 Intermediate Similarity NPC88013
0.7864 Intermediate Similarity NPC234160
0.7864 Intermediate Similarity NPC470169
0.7864 Intermediate Similarity NPC470170
0.7864 Intermediate Similarity NPC125423
0.7857 Intermediate Similarity NPC472989
0.7857 Intermediate Similarity NPC207617
0.785 Intermediate Similarity NPC181145
0.7849 Intermediate Similarity NPC471411
0.7849 Intermediate Similarity NPC471368
0.7849 Intermediate Similarity NPC471410
0.7843 Intermediate Similarity NPC473127
0.7843 Intermediate Similarity NPC470059
0.7843 Intermediate Similarity NPC470057
0.7843 Intermediate Similarity NPC470061
0.7843 Intermediate Similarity NPC470062
0.7843 Intermediate Similarity NPC470064
0.7843 Intermediate Similarity NPC110656
0.7843 Intermediate Similarity NPC470043
0.7843 Intermediate Similarity NPC203354
0.7843 Intermediate Similarity NPC93352
0.7843 Intermediate Similarity NPC470058
0.7843 Intermediate Similarity NPC470060
0.7835 Intermediate Similarity NPC477722
0.7826 Intermediate Similarity NPC471367
0.7822 Intermediate Similarity NPC472815
0.7822 Intermediate Similarity NPC238397
0.7822 Intermediate Similarity NPC201191
0.7822 Intermediate Similarity NPC471363
0.7818 Intermediate Similarity NPC135369
0.7812 Intermediate Similarity NPC477749
0.781 Intermediate Similarity NPC177047
0.781 Intermediate Similarity NPC103627
0.781 Intermediate Similarity NPC191439
0.781 Intermediate Similarity NPC170974
0.7802 Intermediate Similarity NPC103171
0.78 Intermediate Similarity NPC477968
0.78 Intermediate Similarity NPC469942
0.78 Intermediate Similarity NPC130792
0.78 Intermediate Similarity NPC219285
0.78 Intermediate Similarity NPC20113
0.78 Intermediate Similarity NPC228251
0.78 Intermediate Similarity NPC324841
0.78 Intermediate Similarity NPC477972
0.78 Intermediate Similarity NPC161527
0.78 Intermediate Similarity NPC477971
0.7798 Intermediate Similarity NPC83287
0.7789 Intermediate Similarity NPC59682
0.7788 Intermediate Similarity NPC295389
0.7788 Intermediate Similarity NPC311223
0.7788 Intermediate Similarity NPC80210
0.7788 Intermediate Similarity NPC38376
0.7788 Intermediate Similarity NPC295980
0.7788 Intermediate Similarity NPC224414
0.7788 Intermediate Similarity NPC230888

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474835 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8317 Intermediate Similarity NPD6686 Approved
0.7925 Intermediate Similarity NPD8133 Approved
0.7798 Intermediate Similarity NPD7327 Approved
0.7798 Intermediate Similarity NPD7328 Approved
0.7748 Intermediate Similarity NPD7503 Approved
0.7727 Intermediate Similarity NPD7516 Approved
0.7658 Intermediate Similarity NPD8294 Approved
0.7658 Intermediate Similarity NPD8377 Approved
0.7589 Intermediate Similarity NPD8378 Approved
0.7589 Intermediate Similarity NPD8033 Approved
0.7589 Intermediate Similarity NPD8296 Approved
0.7589 Intermediate Similarity NPD8380 Approved
0.7589 Intermediate Similarity NPD8379 Approved
0.7589 Intermediate Similarity NPD8335 Approved
0.7524 Intermediate Similarity NPD6412 Phase 2
0.7453 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7328 Intermediate Similarity NPD7507 Approved
0.7222 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7319 Approved
0.7048 Intermediate Similarity NPD5344 Discontinued
0.7019 Intermediate Similarity NPD7638 Approved
0.7019 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.6952 Remote Similarity NPD7639 Approved
0.6952 Remote Similarity NPD7640 Approved
0.6937 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6869 Remote Similarity NPD7524 Approved
0.6864 Remote Similarity NPD8328 Phase 3
0.6857 Remote Similarity NPD4225 Approved
0.6832 Remote Similarity NPD46 Approved
0.6832 Remote Similarity NPD7838 Discovery
0.6832 Remote Similarity NPD6698 Approved
0.6783 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6757 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6735 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6735 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6695 Remote Similarity NPD8515 Approved
0.6695 Remote Similarity NPD8516 Approved
0.6695 Remote Similarity NPD8517 Approved
0.6695 Remote Similarity NPD6921 Approved
0.6695 Remote Similarity NPD8513 Phase 3
0.6639 Remote Similarity NPD6370 Approved
0.6639 Remote Similarity NPD7736 Approved
0.6636 Remote Similarity NPD6648 Approved
0.6633 Remote Similarity NPD6695 Phase 3
0.6633 Remote Similarity NPD3670 Clinical (unspecified phase)
0.6633 Remote Similarity NPD3669 Approved
0.6602 Remote Similarity NPD7637 Suspended
0.6569 Remote Similarity NPD6051 Approved
0.6559 Remote Similarity NPD1810 Approved
0.6559 Remote Similarity NPD1811 Approved
0.6557 Remote Similarity NPD8293 Discontinued
0.6538 Remote Similarity NPD8171 Discontinued
0.6529 Remote Similarity NPD7492 Approved
0.6496 Remote Similarity NPD6009 Approved
0.6496 Remote Similarity NPD7115 Discovery
0.6475 Remote Similarity NPD6616 Approved
0.6471 Remote Similarity NPD6054 Approved
0.6442 Remote Similarity NPD6411 Approved
0.6435 Remote Similarity NPD6882 Approved
0.6423 Remote Similarity NPD7078 Approved
0.6404 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6381 Remote Similarity NPD6399 Phase 3
0.6379 Remote Similarity NPD4632 Approved
0.6373 Remote Similarity NPD7750 Discontinued
0.6364 Remote Similarity NPD7632 Discontinued
0.6333 Remote Similarity NPD6319 Approved
0.6333 Remote Similarity NPD6059 Approved
0.6327 Remote Similarity NPD7525 Registered
0.6327 Remote Similarity NPD6930 Phase 2
0.6327 Remote Similarity NPD6931 Approved
0.6296 Remote Similarity NPD6083 Phase 2
0.6296 Remote Similarity NPD6084 Phase 2
0.6293 Remote Similarity NPD8297 Approved
0.6286 Remote Similarity NPD8035 Phase 2
0.6286 Remote Similarity NPD8034 Phase 2
0.6286 Remote Similarity NPD7983 Approved
0.6281 Remote Similarity NPD6016 Approved
0.6281 Remote Similarity NPD6015 Approved
0.6261 Remote Similarity NPD6371 Approved
0.625 Remote Similarity NPD8170 Clinical (unspecified phase)
0.625 Remote Similarity NPD6101 Approved
0.625 Remote Similarity NPD5764 Clinical (unspecified phase)
0.625 Remote Similarity NPD6933 Approved
0.6237 Remote Similarity NPD2686 Approved
0.6237 Remote Similarity NPD2687 Approved
0.6237 Remote Similarity NPD7532 Clinical (unspecified phase)
0.6237 Remote Similarity NPD2254 Approved
0.623 Remote Similarity NPD5988 Approved
0.6228 Remote Similarity NPD6899 Approved
0.6228 Remote Similarity NPD6881 Approved
0.6226 Remote Similarity NPD5779 Approved
0.6226 Remote Similarity NPD5778 Approved
0.6224 Remote Similarity NPD6929 Approved
0.6224 Remote Similarity NPD7645 Phase 2
0.621 Remote Similarity NPD8451 Approved
0.62 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6195 Remote Similarity NPD6675 Approved
0.6195 Remote Similarity NPD7128 Approved
0.6195 Remote Similarity NPD5739 Approved
0.6195 Remote Similarity NPD6402 Approved
0.6186 Remote Similarity NPD6932 Approved
0.6179 Remote Similarity NPD6067 Discontinued
0.6176 Remote Similarity NPD7625 Phase 1
0.6176 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6168 Remote Similarity NPD7748 Approved
0.6162 Remote Similarity NPD7514 Phase 3
0.6162 Remote Similarity NPD7332 Phase 2
0.6162 Remote Similarity NPD6928 Phase 2
0.616 Remote Similarity NPD8448 Approved
0.616 Remote Similarity NPD8074 Phase 3
0.6154 Remote Similarity NPD6053 Discontinued
0.6147 Remote Similarity NPD7902 Approved
0.6142 Remote Similarity NPD8390 Approved
0.6142 Remote Similarity NPD8391 Approved
0.6142 Remote Similarity NPD8392 Approved
0.614 Remote Similarity NPD5954 Clinical (unspecified phase)
0.614 Remote Similarity NPD5697 Approved
0.6132 Remote Similarity NPD7087 Discontinued
0.6132 Remote Similarity NPD7515 Phase 2
0.6122 Remote Similarity NPD7145 Approved
0.6121 Remote Similarity NPD6883 Approved
0.6121 Remote Similarity NPD7102 Approved
0.6121 Remote Similarity NPD7290 Approved
0.61 Remote Similarity NPD1779 Approved
0.61 Remote Similarity NPD1780 Approved
0.6098 Remote Similarity NPD5125 Phase 3
0.6098 Remote Similarity NPD5126 Approved
0.6087 Remote Similarity NPD7320 Approved
0.6068 Remote Similarity NPD6650 Approved
0.6068 Remote Similarity NPD8130 Phase 1
0.6068 Remote Similarity NPD6649 Approved
0.6068 Remote Similarity NPD6847 Approved
0.6068 Remote Similarity NPD6617 Approved
0.6068 Remote Similarity NPD6869 Approved
0.6048 Remote Similarity NPD7830 Approved
0.6048 Remote Similarity NPD7604 Phase 2
0.6048 Remote Similarity NPD7829 Approved
0.6042 Remote Similarity NPD6924 Approved
0.6042 Remote Similarity NPD6926 Approved
0.6038 Remote Similarity NPD3168 Discontinued
0.6034 Remote Similarity NPD6012 Approved
0.6034 Remote Similarity NPD6014 Approved
0.6034 Remote Similarity NPD6372 Approved
0.6034 Remote Similarity NPD6013 Approved
0.6034 Remote Similarity NPD6373 Approved
0.602 Remote Similarity NPD6925 Approved
0.602 Remote Similarity NPD5776 Phase 2
0.6019 Remote Similarity NPD6893 Approved
0.6016 Remote Similarity NPD8444 Approved
0.6016 Remote Similarity NPD5983 Phase 2
0.6 Remote Similarity NPD8340 Approved
0.6 Remote Similarity NPD8341 Approved
0.6 Remote Similarity NPD8342 Approved
0.6 Remote Similarity NPD8299 Approved
0.6 Remote Similarity NPD5701 Approved
0.6 Remote Similarity NPD6940 Discontinued
0.6 Remote Similarity NPD7899 Clinical (unspecified phase)
0.5979 Remote Similarity NPD6942 Approved
0.5979 Remote Similarity NPD7339 Approved
0.5963 Remote Similarity NPD5695 Phase 3
0.5962 Remote Similarity NPD7334 Approved
0.5962 Remote Similarity NPD7521 Approved
0.5962 Remote Similarity NPD6684 Approved
0.5962 Remote Similarity NPD7146 Approved
0.5962 Remote Similarity NPD6409 Approved
0.5962 Remote Similarity NPD5330 Approved
0.5952 Remote Similarity NPD6336 Discontinued
0.5948 Remote Similarity NPD6011 Approved
0.5946 Remote Similarity NPD5696 Approved
0.5941 Remote Similarity NPD6898 Phase 1
0.5941 Remote Similarity NPD6902 Approved
0.5923 Remote Similarity NPD8449 Approved
0.5922 Remote Similarity NPD4786 Approved
0.592 Remote Similarity NPD7642 Approved
0.5918 Remote Similarity NPD3701 Clinical (unspecified phase)
0.5913 Remote Similarity NPD6640 Phase 3
0.5909 Remote Similarity NPD4792 Clinical (unspecified phase)
0.5909 Remote Similarity NPD7839 Suspended
0.5905 Remote Similarity NPD4751 Clinical (unspecified phase)
0.5905 Remote Similarity NPD4251 Approved
0.5905 Remote Similarity NPD4250 Approved
0.5902 Remote Similarity NPD7641 Discontinued
0.59 Remote Similarity NPD6683 Phase 2
0.5891 Remote Similarity NPD5956 Approved
0.5882 Remote Similarity NPD3667 Approved
0.5878 Remote Similarity NPD8450 Suspended
0.5872 Remote Similarity NPD7901 Clinical (unspecified phase)
0.5872 Remote Similarity NPD7900 Approved
0.5872 Remote Similarity NPD5282 Discontinued
0.5865 Remote Similarity NPD7966 Clinical (unspecified phase)
0.5865 Remote Similarity NPD6082 Clinical (unspecified phase)
0.5859 Remote Similarity NPD6033 Approved
0.5849 Remote Similarity NPD7513 Clinical (unspecified phase)
0.5849 Remote Similarity NPD6903 Approved
0.5849 Remote Similarity NPD5737 Approved
0.5849 Remote Similarity NPD6672 Approved
0.5847 Remote Similarity NPD4634 Approved
0.5842 Remote Similarity NPD4820 Approved
0.5842 Remote Similarity NPD4819 Approved
0.5842 Remote Similarity NPD4821 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data